{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T11:42:26Z","timestamp":1793101346273,"version":"4.5.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"name":"Intramural Research Program of the NIH"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["ZIA BC011028"],"award-info":[{"award-number":["ZIA BC011028"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["ZIA BC011038"],"award-info":[{"award-number":["ZIA BC011038"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["ZID BC011089"],"award-info":[{"award-number":["ZID BC011089"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["ZIC BC011044"],"award-info":[{"award-number":["ZIC BC011044"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the genetic, phenotypic, and pathologic manifestations of patients presenting with inherited kidney cancer and germline variants of the Tuberous Sclerosis Complex (TSC) genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Inherited kidney cancer patients were screened for germline RCC susceptibility gene variants and patient histories and clinical evaluations were performed. Renal tumors were evaluated for somatic genetic alterations by DNA sequencing and mRNA expression analysis by RNAseq and immunohistochemical analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine distinct germline TSC1\/TSC2 variants were identified in 13 patients, including seven known or likely pathogenic alterations. Five patients presented with a clinical diagnosis of TSC, and eleven patients had a genetic diagnosis of TSC. Nine patients had bilateral RCC and nine had multifocal RCC. The average initial age at diagnosis of RCC was 47\u00a0years old. The TSC-associated tumors demonstrated a variety of histologies including ccRCC, RCC with clear cell and papillary features, chromophobe RCC, and oncocytoma; with ccRCC being the most prevalent. Loss of heterozygosity or secondary somatic alteration of TSC1\/TSC2 was observed in ~\u200937% of tumors. RNAseq analysis demonstrated specific expression patterns associated within histologically defined tumor clusters and increased expression of CLEAR genes activated by the TFE3\/TFEB transcription factors, including GPNMB and NPC1 which were confirmed with immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study confirms the importance of screening individuals with a family history of kidney cancer for TSC1\/TSC2 germline variants, even in the absence of canonical TSC manifestations, and indicates a critical role of TFE3 and TFEB as drivers of human TSC-deficient renal cell carcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/hmg\/ddaf173","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:20:01Z","timestamp":1762874401000},"source":"Crossref","is-referenced-by-count":3,"title":["Tuberous sclerosis complex-associated renal cell carcinoma, an underappreciated form of familial renal cancer, is characterized by activation of the TFEB\/TFE3 pathway"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4814-7207","authenticated-orcid":false,"given":"Christopher J","family":"Ricketts","sequence":"first","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9256-7607","authenticated-orcid":false,"given":"Cathy D","family":"Vocke","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lang","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Medina","family":"Velazquez","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi S","family":"Srirama","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R","family":"Crooks","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionna","family":"Gamble","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Di Malta","sequence":"additional","affiliation":[{"name":"Telethon Institute of Genetics and Medicine (TIGEM) and Medical Genetics Unit, Department of Medical and Translational Science, Federico II University , 34 Via Campi Flegrei, 80078, Pozzuoli, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabindra","family":"Gautam","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Merino","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ballabio","sequence":"additional","affiliation":[{"name":"Telethon Institute of Genetics and Medicine (TIGEM) and Medical Genetics Unit, Department of Medical and Translational Science, Federico II University , 34 Via Campi Flegrei, 80078, Pozzuoli, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W","family":"Ball","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Marston","family":"Linehan","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , 9000 Rockville Pike, Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2026051101323672200_ref1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: a metabolic disease","volume":"7","author":"Linehan","year":"2010","journal-title":"Nat Rev Urol"},{"key":"2026051101323672200_ref2","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1158\/2159-8290.CD-18-1354","article-title":"The metabolic basis of kidney cancer","volume":"9","author":"Linehan","year":"2019","journal-title":"Cancer Discov"},{"key":"2026051101323672200_ref3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"2026051101323672200_ref4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"The European Chromosome 16 Tuberous Sclerosis, C","year":"1993","journal-title":"Cell"},{"key":"2026051101323672200_ref5","first-page":"1201","article-title":"Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features","volume":"149","author":"Bjornsson","year":"1996","journal-title":"Am J Pathol"},{"key":"2026051101323672200_ref6","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2026051101323672200_ref7","doi-asserted-by":"publisher","DOI":"10.3390\/genes12101585","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"12","author":"Henske","year":"2021","journal-title":"Genes (Basel)"},{"key":"2026051101323672200_ref8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"2026051101323672200_ref9","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026051101323672200_ref10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"2026051101323672200_ref11","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"2026051101323672200_ref12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","article-title":"An epidemiological study of renal pathology in tuberous sclerosis complex","volume":"94","author":"O'Callaghan","year":"2004","journal-title":"BJU Int"},{"key":"2026051101323672200_ref13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","article-title":"Renal disease in tuberous sclerosis complex: pathogenesis and therapy","volume":"14","author":"Lam","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2026051101323672200_ref14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/0090-4295(91)80261-5","article-title":"Malignant renal tumors in tuberous sclerosis","volume":"37","author":"Washecka","year":"1991","journal-title":"Urology"},{"key":"2026051101323672200_ref15","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1093\/hmg\/3.10.1833","article-title":"The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor","volume":"3","author":"Green","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2026051101323672200_ref16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/ng0294-193","article-title":"Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients","volume":"6","author":"Green","year":"1994","journal-title":"Nat Genet"},{"key":"2026051101323672200_ref17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2026051101323672200_ref18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype \u2013 phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"2026051101323672200_ref19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","article-title":"Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States","volume":"9","author":"Au","year":"2007","journal-title":"Genet Med"},{"key":"2026051101323672200_ref20","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1136\/jmg.37.5.e3","article-title":"Genotype-phenotype correlations in tuberous sclerosis","volume":"37","author":"De Vries","year":"2000","journal-title":"J Med Genet"},{"key":"2026051101323672200_ref21","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","article-title":"Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma","volume":"361","author":"El-Hashemite","year":"2003","journal-title":"Lancet"},{"key":"2026051101323672200_ref22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"2026051101323672200_ref23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2026051101323672200_ref24","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1038\/s41467-021-24499-6","article-title":"TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism","volume":"12","author":"Alesi","year":"2021","journal-title":"Nat Commun"},{"key":"2026051101323672200_ref25","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.tcb.2022.04.012","article-title":"Non-canonical mTORC1 signaling at the lysosome","volume":"32","author":"Napolitano","year":"2022","journal-title":"Trends Cell Biol"},{"key":"2026051101323672200_ref26","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1038\/s41467-022-34617-7","article-title":"An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-rag activation in renal cells with TSC2 loss","volume":"13","author":"Asrani","year":"2022","journal-title":"Nat Commun"},{"key":"2026051101323672200_ref27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","article-title":"A substrate-specific mTORC1 pathway underlies Birt-hogg-Dube syndrome","volume":"585","author":"Napolitano","year":"2020","journal-title":"Nature"},{"key":"2026051101323672200_ref28","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nrurol.2015.206","article-title":"Molecular genetics and clinical features of Birt-hogg-Dube syndrome","volume":"12","author":"Schmidt","year":"2015","journal-title":"Nat Rev Urol"},{"key":"2026051101323672200_ref29","doi-asserted-by":"publisher","first-page":"e16877","DOI":"10.15252\/emmm.202216877","article-title":"TFEB and TFE3 drive kidney cystogenesis and tumorigenesis","volume":"15","author":"Di Malta","year":"2023","journal-title":"EMBO Mol Med"},{"key":"2026051101323672200_ref30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrurol.2014.162","article-title":"Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers","volume":"11","author":"Kauffman","year":"2014","journal-title":"Nat Rev Urol"},{"key":"2026051101323672200_ref31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/gcc.23007","article-title":"Translocation carcinomas of the kidney","volume":"61","author":"Argani","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"2026051101323672200_ref32","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","article-title":"Evaluation and management of renal tumors in the Birt-hogg-Dube syndrome","volume":"173","author":"Pavlovich","year":"2005","journal-title":"J Urol"},{"key":"2026051101323672200_ref33","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/humu.21451","article-title":"Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with tuberous sclerosis complex","volume":"32","author":"Hoogeveen-Westerveld","year":"2011","journal-title":"Hum Mutat"},{"key":"2026051101323672200_ref34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-0004.2011.01648.x","article-title":"Functional characterization of the TSC2 c.3598C&gt;T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds","volume":"81","author":"Wentink","year":"2012","journal-title":"Clin Genet"},{"key":"2026051101323672200_ref35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1600-0404.2004.00366.x","article-title":"Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex","volume":"111","author":"Ali","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"2026051101323672200_ref36","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/ejhg.2015.47","article-title":"Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2","volume":"23","author":"Kwiatkowski","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"2026051101323672200_ref37","doi-asserted-by":"publisher","first-page":"e0185713","DOI":"10.1371\/journal.pone.0185713","article-title":"Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis","volume":"12","author":"Rosset","year":"2017","journal-title":"PLoS One"},{"key":"2026051101323672200_ref38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ana.21037","article-title":"Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation","volume":"60","author":"Jansen","year":"2006","journal-title":"Ann Neurol"},{"key":"2026051101323672200_ref39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/jmg.38.5.347","article-title":"A novel missense mutation in the GTPase activating protein homology region of TSC2 in two large families with tuberous sclerosis complex","volume":"38","author":"Khare","year":"2001","journal-title":"J Med Genet"},{"key":"2026051101323672200_ref40","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2026051101323672200_ref41","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat Genet"},{"key":"2026051101323672200_ref42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Network., C. G. A.R","year":"2013","journal-title":"Nature"},{"key":"2026051101323672200_ref43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"2026051101323672200_ref44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1755-148X.2008.00505.x","article-title":"Novel MITF targets identified using a two-step DNA microarray strategy","volume":"21","author":"Hoek","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026051101323672200_ref45","doi-asserted-by":"publisher","first-page":"e95157","DOI":"10.1371\/journal.pone.0095157","article-title":"Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype","volume":"9","author":"Hartman","year":"2014","journal-title":"PLoS One"},{"key":"2026051101323672200_ref46","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum Mol Genet"},{"key":"2026051101323672200_ref47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2013.03.012","article-title":"Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3","volume":"153","author":"Betschinger","year":"2013","journal-title":"Cell"},{"key":"2026051101323672200_ref48","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s41379-021-00803-z","article-title":"TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma","volume":"34","author":"Wang","year":"2021","journal-title":"Mod Pathol"},{"key":"2026051101323672200_ref49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"2026051101323672200_ref50","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/hmg\/ddu597","article-title":"A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex","volume":"24","author":"Tyburczy","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2026051101323672200_ref51","doi-asserted-by":"publisher","first-page":"a002220","DOI":"10.1101\/mcs.a002220","article-title":"Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation-associated metastatic renal-cell carcinoma","volume":"4","author":"Alsidawi","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"2026051101323672200_ref52","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1136\/jmg.32.11.848","article-title":"Multifocal renal cell carcinoma in sibs from a chromosome 9 linked (TSC1) tuberous sclerosis family","volume":"32","author":"Sampson","year":"1995","journal-title":"J Med Genet"},{"key":"2026051101323672200_ref53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1442-2042.1997.tb00147.x","article-title":"Bilateral chromophobe cell renal carcinoma in tuberous sclerosis complex","volume":"4","author":"Hidai","year":"1997","journal-title":"Int J Urol"},{"key":"2026051101323672200_ref54","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MOU.0000000000000094","article-title":"Nephron-sparing surgery for multifocal and hereditary renal tumors","volume":"24","author":"Metwalli","year":"2014","journal-title":"Curr Opin Urol"},{"key":"2026051101323672200_ref55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/CE.S98687","article-title":"Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy","volume":"11","author":"Buti","year":"2016","journal-title":"Core Evid"},{"key":"2026051101323672200_ref56","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"2026051101323672200_ref57","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"2026051101323672200_ref58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2026051101323672200_ref59","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10147-017-1224-9","article-title":"Effect of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: an evaluation based on tumor density","volume":"23","author":"Hatano","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"2026051101323672200_ref60","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13023-016-0517-9","article-title":"Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial","volume":"11","author":"Robles","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"2026051101323672200_ref61","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJMoa2035716","article-title":"Lenvatinib plus pembrolizumab or Everolimus for advanced renal cell carcinoma","volume":"384","author":"Motzer","year":"2021","journal-title":"N Engl J Med"},{"key":"2026051101323672200_ref62","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1126\/science.aag2553","article-title":"Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth","volume":"356","author":"Di Malta","year":"2017","journal-title":"Science"},{"key":"2026051101323672200_ref63","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"key":"2026051101323672200_ref64","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1200\/JCO.2014.56.2959","article-title":"EMERGE: a randomized phase II study of the antibody-drug conjugate Glembatumumab Vedotin in advanced glycoprotein NMB-expressing breast cancer","volume":"33","author":"Yardley","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026051101323672200_ref65","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/cncr.31892","article-title":"A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma","volume":"125","author":"Ott","year":"2019","journal-title":"Cancer"},{"key":"2026051101323672200_ref66","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082270","article-title":"A phase II study of Glembatumumab Vedotin for metastatic uveal melanoma","volume":"12","author":"Hasanov","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026051101323672200_ref67","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1158\/1541-7786.MCR-18-1235","article-title":"TFE3 Xp11.2 translocation renal cell carcinoma mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease","volume":"17","author":"Baba","year":"2019","journal-title":"Mol Cancer Res"},{"key":"2026051101323672200_ref68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/cas.12601","article-title":"Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-hogg-Dube syndrome","volume":"106","author":"Furuya","year":"2015","journal-title":"Cancer Sci"},{"key":"2026051101323672200_ref69","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13046-023-02667-4","article-title":"High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma","volume":"42","author":"Lang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"2026051101323672200_ref70","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep"},{"key":"2026051101323672200_ref71","doi-asserted-by":"publisher","first-page":"9906","DOI":"10.1038\/srep09906","article-title":"Triplex real-time PCR\u2013an improved method to detect a wide spectrum of mitochondrial DNA deletions in single cells","volume":"5","author":"Rygiel","year":"2015","journal-title":"Sci Rep"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/35\/1\/ddaf173\/65269699\/ddaf173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/35\/1\/ddaf173\/65269699\/ddaf173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:32:42Z","timestamp":1778477562000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/doi\/10.1093\/hmg\/ddaf173\/8320568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2,8]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddaf173","relation":{},"ISSN":["1460-2083"],"issn-type":[{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2025,11,11]]},"article-number":"ddaf173"}}